Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients

por Wang, Li, Widatalla, Sarrah E., Whalen, Diva S., Ochieng, Josiah, Sakwe, Amos M.
Publicado 2017

Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes

por Ochieng, Josiah, Nangami, Gladys, Sakwe, Amos, Moye, Cierra, Alvarez, Joel, Whalen, Diva, Thomas, Portia, Lammers, Philip
Publicado 2018

Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors

por Widatalla, Sarrah E, Korolkova, Olga Y, Whalen, Diva S, Goodwin, J Shawn, Williams, Kevin P, Ochieng, Josiah, Sakwe, Amos M
Publicado 2019

Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies

por Korolkova, Olga Y., Widatalla, Sarrah E., Williams, Stephen D., Whalen, Diva S., Beasley, Heather K., Ochieng, Josiah, Grewal, Thomas, Sakwe, Amos M.
Publicado 2020

Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer

por Beasley, Heather K., Widatalla, Sarrah E., Whalen, Diva S., Williams, Stephen D., Korolkova, Olga Y., Namba, Clementine, Pratap, Siddharth, Ochieng, Josiah, Sakwe, Amos M.
Publicado 2022

Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility

por Whalen, Diva S., Widatalla, Sarrah E., Korolkova, Olga Y., Nangami, Gladys S., Beasley, Heather K., Williams, Stephen D., Virgous, Carlos, Lehmann, Brian D., Ochieng, Josiah, Sakwe, Amos M.
Publicado 2019

Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets

por Korolkova, Olga Y., Widatalla, Sarrah E., Whalen, Diva S., Nangami, Gladys N., Abimbola, Adeniyi, Williams, Stephen D., Beasley, Heather K., Reisenbichler, Emily, Washington, Mary Kay, Ochieng, Josiah, Mayer, Ingrid A., Lehmann, Brian D., Sakwe, Amos M.
Publicado 2020